Larkspur Biosciences

Home - Larkspur Bioscience

Cambridge, United States · Founded 2023

Founded
2023
Business Model
B2B
Last Round
SeedMay 2023
Rounds
1

About

Larkspur Biosciences is a Cambridge, Massachusetts-based biotechnology company developing first-in-class protein degraders that target cancer cell fitness genes to destroy tumors more effectively. Its most advanced program, LRK-4189, applies this approach to microsatellite stable colorectal cancer, a historically difficult-to-treat tumor type. The company was founded by Lewis C. Cantley, Nathanael Gray, and Vijay K. Kuchroo and launched in 2023 with $35.5 million in financing, backed by investors including Polaris Partners, 3E Bioventures Capital, Takeda Ventures, and Creacion Ventures.

Summary

Larkspur Biosciences is a Biotech company based in Cambridge, United States, founded in 2023. Its most recent funding was a Seed round in May 2023.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMay 2023

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Larkspur Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/larkspur-biosciences"><img src="https://indexed.vc/api/badge/company/larkspur-biosciences" alt="Larkspur Biosciences on Indexed.vc" width="260" height="76" /></a>